Baseline characteristics of the head-to-head studies comparing ranibizumab with bevacizumab.
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/_Baseline_characteristics_of_the_head_to_head_studies_comparing_ranibizumab_with_bevacizumab_/1207165
下载链接
链接失效反馈官方服务：
资源简介：
CATT = The Comparison of Age-related macular degeneration Treatments Trials; IVAN = The Alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularization study; MANTA = The Multicenter Anti-VEGF Trial; GEFAL = The Groupe d'Etude Français Avastin versus Lucentis dans la DMLA néovasculaire (The French Study Group Avastin versus Lucentis for neovascular AMD).
Baseline characteristics of the head-to-head studies comparing ranibizumab with bevacizumab.
创建时间：
2014-10-16
